In line with previous meta-analyses finding elevated CSF NfL concentration in MS patients [7, 53–55], the present study demonstrates NfL levels in blood, which are strongly correlated with those in CSF, are also significantly higher in MS patients compared with controls. This evidence concerns the gene NEFL and myeloid sarcoma.